Header Logo

Drotrecogin alfa (activated) in sepsis: initial experience with patient selection, cost, and clinical outcomes.

Higgins TL, Steingrub JS, Tereso GJ, Tidswell MA, McGee WT. Drotrecogin alfa (activated) in sepsis: initial experience with patient selection, cost, and clinical outcomes. J Intensive Care Med. 2005 Nov-Dec; 20(6):339-45.

View in: PubMed